- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Early Intervention in Bipolar Disorder
During this webinar, Dr. Goldberg and Dr. Tohen will discuss the importance of early intervention in patients diagnosed with bipolar disorder. Together they will share their clinical experience and discuss the implications of early versus delayed intervention and identify and explore potential treatment options in bipolar disorder.
Objectives:
- Describe the implications of early versus later intervention in bipolar disorder
- Explore suitable treatment options in bipolar disorder
Featuring
Joseph Goldberg, MD
Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai
MoreDr. Goldberg currently serves as the Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai and serves on the Board of Directors for the American Society of Clinical Psychopharmacology. Dr. Goldberg has published over 200 peer-reviewed papers on topics related to the treatment and clinical features of bipolar disorder, as well as three books on bipolar disorder and psychopharmacology.Mauricio Tohen, MD, DrPH, MBA
Chairman, Department of Psychiatry, University Distinguished Professor, University of New Mexico Health Science Center
MoreMauricio Tohen, MD, DrPH, MBA, is a University Distinguished Professor and Chairman of the Department of Psychiatry at the University of New Mexico Health Science Center, Albuquerque NM. From 2009 to 2013 he was a Professor of Psychiatry and The Krus Endowed Chair in Psychiatry at the University of Texas Health Science Center at San Antonio. Dr. Tohen received his medical degree from the National University of Mexico and his Doctor of Public Health degree in Epidemiology from Harvard University. His postdoctoral training included a residency in Psychiatry at the University of Toronto, a clinical fellowship at McLean Hospital and Harvard Medical School, and a teaching fellowship in Epidemiology at the Harvard School of Public Health. From 1988 to 1997, Dr. Tohen was the Clinical Director of the Bipolar and Psychotic Disorders Program at McLean Hospital. From 1997 to 2008 he was a member of Lilly Research Laboratories reaching the senior-most scientific level of Distinguished Lilly Scholar. In 2009 he joined the University of Texas Health Science Center at San Antonio as the Head of the Division of Mood and Anxiety Disorders. Dr. Tohen received a National Service Award in Psychiatric Epidemiology from the National Institute of Mental Health (NIMH) and Harvard University. He also received a FIRST award from the NIMH, the Pope Award from McLean Hospital, and a NARSAD Young Investigator Award and the Simon Bolivar Award from the American Psychiatric Association. In 2014 he was named by Thomson Reuter’s “The World’s Most Influential Scientific Minds, 2014”. Honorees were the scientists who ranked in the Top 1 percent by citations of their published work in 21 broad fields between 2002 and 2012.Jason Carter, PharmD (OPDC)
Senior Medical Science Liaison, Neuroscience Field Medical Affairs
Speakers Dr. Joseph Goldberg and Dr. Mauricio Tohen are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Jason Carter, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Related Events
-
The Danger of Post-Traumatic Stress Disorder (PTSD) Stigma Among Marginalized Communities
October 10 12:00 pm to 1:00 pm
Registration
Related Resources
-
Understanding Digital Therapeutics
Infographic April 22, 2024Digital therapeutics (DTx) deliver software-based interventions to patients to treat, manage, or prevent a disease or condition.
-
Understanding MDD Treatments With Neuroplastic Effects
Infographic April 22, 2024Researchers are exploring whether it is possible to leverage neuroplasticity to develop treatments for depression.
-
Understanding Neuroplasticity In Depression
Infographic April 22, 2024The brain is constantly changing! The ability of the brain to create, reorganize, or eliminate connections between neurons (synapses) and change how its circuits are wired is called neuroplasticity.
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected: